Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A bacterial biofilm is a structured community of bacterial cells surrounded by a self-produced polymeric matrix (composed primarily of polysaccharides, proteins, and extracellular DNA) that adheres to biotic or abiotic surfaces[1][3][4]. Biofilm formation is a multistep process involving initial planktonic bacterial attachment, microcolony formation, matrix production, and ultimately maturation and dispersal[1][4][7]. Within a biofilm, bacteria become highly resistant to antibiotics and host immune response, largely due to the physical barrier of the matrix, altered metabolic states (including dormant persister cells), and enhanced horizontal gene transfer, making biofilms a key driver of chronic and device-related infections and a major obstacle in infection eradication[5][4][6].
Inhibition of bacterial adhesion; Disruption of matrix (e.g., DNase degrades extracellular DNA); Quorum sensing interference; Killing/detachment of sessile cells; Targeting dormant persister cells
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial biofilm growth.